An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
Affiliation
Université Catholique de Louvain, Cliniques universitaires St Luc, Bruxelles, Belgium. etienne.sokal@uclouvain.be
Authors
Bourgois A, Fischler B, Gardovska D, Kelly D, Porta G, Silveira T, Sokal EM, Stéphenne X
Studies
Citation
Sokal EM, Bourgois A, Stéphenne X, Silveira T, Porta G, Gardovska D, Fischler B, Kelly D. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents. J Hepatol 2010 Jun;52(6):827-31. Epub 2010 Mar 15.Abstract
This multi-center study aimed to prospectively evaluate the safety and efficacy of a genotype-based Pegylated Interferon alfa-2a/Ribavirin therapy in treatment-naïve hepatitis C virus (HCV), positive HCV serology, and quantifiable HCV RNA, infected children.